Invention Grant
- Patent Title: Line leaf inula flower lactone A and methods for preparing and using the same for treating multiple sclerosis
- Patent Title (中): 线叶内花内酯A及其制备方法及其用于治疗多发性硬化
-
Application No.: US14576164Application Date: 2014-12-18
-
Publication No.: US09278948B2Publication Date: 2016-03-08
- Inventor: Weidong Zhang , Lei Shan , Juan Su , Huizi Jin , Huiliang Li , Yunheng Shen , Xike Xu , Runhui Liu
- Applicant: SHANXI ZHENDONG PILOT BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD.
- Applicant Address: CN Jinzhong
- Assignee: Shanxi Zhendong Pilot Biological Science And Technology Co., Ltd.
- Current Assignee: Shanxi Zhendong Pilot Biological Science And Technology Co., Ltd.
- Current Assignee Address: CN Jinzhong
- Agency: Mei & Mark LLP
- Agent Manni Li
- Priority: CN201210208157 20120621
- Main IPC: C07D307/00
- IPC: C07D307/00 ; C07D307/93 ; A61K9/19 ; A61K31/365 ; A61K36/28 ; A61K9/00 ; A61K9/20

Abstract:
Preparation and application of line leaf inula flower lactone A in the multiple sclerosis, having a structure of Line leaf inula flower lactone A has therapeutic effects on experimental autoimmune encephalomyelitis (EAE) model, and is used to develop drug for treating multiple sclerosis (MS). Line leaf inula flower lactone A drug is a combination containing the active ingredient of line leaf inula flower lactone A and conventional pharmaceutically carrier, and may be in forms of tablets, dispersible tablets, mouth collapse tablets, retard tablets, capsule, soft capsule, dropping pill, granules, injection, powder injection, or aerosol. The pharmaceutical composition is used for treating multiple sclerosis, has tremendous developing potentiality because of its high value of clinical application.
Public/Granted literature
Information query